Study Evaluating Oral Administrations of HKI-272 in Healthy Male Subjects

Puma Biotechnology, Inc.6 enrolled

Overview

The purpose of this study is to evaluate the mass balance and metabolic distribution of C14-labeled HKI-272 in healthy male subjects.

Study Type

INTERVENTIONAL

Allocation

NON_RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

HKI-272, Single-dose capsule and solution

Sex: MALEMin age: 18 YearsMax age: 50 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Healthy male subjects, aged 18 to 50 years. Exclusion Criteria: * Female subjects

Mass balance, metabolic distribution, PK

Time frame: 10 days

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.